» Articles » PMID: 7622099

New Gynecologic Cancer Staging

Overview
Journal Gynecol Oncol
Date 1995 Aug 1
PMID 7622099
Citations 20
Authors
Affiliations
Soon will be listed here.
Citing Articles

A Case for the Conservative Management of Stage IA Cervical Cancer.

Blackman A, Creasman W Cancers (Basel). 2023; 15(20).

PMID: 37894417 PMC: 10605599. DOI: 10.3390/cancers15205051.


Immunotherapies landscape and associated inhibitors for the treatment of cervical cancer.

Yadav A, Yadav S, Alam M Med Oncol. 2023; 40(11):328.

PMID: 37815596 DOI: 10.1007/s12032-023-02188-2.


Invasive Cervical Cancer After a Positive Pap Test Result and Negative Human Papillomavirus Test Result.

Locke A, Shah N, Fetterman B, Poitras N, Wi S, Castle P Obstet Gynecol. 2021; 138(4):580-581.

PMID: 34623071 PMC: 8849518. DOI: 10.1097/AOG.0000000000004543.


The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.

Poetsch N, Sturdza A, Aust S, Polterauer S, Grimm C, Schwameis R Strahlenther Onkol. 2019; 195(5):430-440.

PMID: 30737542 PMC: 6488555. DOI: 10.1007/s00066-019-01430-z.


Prognostic value and clinicopathologic characteristics of L1 cell adhesion molecule (L1CAM) in a large series of vulvar squamous cell carcinomas.

Trietsch M, Oonk M, Hawinkels L, Bor R, van Eendenburg J, Ivanova Z Oncotarget. 2016; 7(18):26192-205.

PMID: 27028855 PMC: 5041974. DOI: 10.18632/oncotarget.8353.